Protease-activated receptor 2 in dorsal root ganglion contributes to peripheral sensitization of bone cancer pain

European Journal of Pain (United Kingdom)

Volumn 18, Issue 3, 2014, Pages 326-337

  Liu, S ^a,b   Liu, Y P ^a,b   Yue, D M ^a   Liu, G J ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b Parker University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM ION; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE C GAMMA; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 2; H-PHE-SER-LEU-LEU-ARG-TYR-NH2; OLIGOPEPTIDE;

ADULT; ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE CANCER; BONE PAIN; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CANCER PAIN; CANCER PATIENT; CHEMOPROPHYLAXIS; CONTROLLED STUDY; ENZYME RELEASE; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; NEUROCHEMISTRY; NONHUMAN; ONCOGENE C FOS; PAIN ASSESSMENT; PERIPHERAL SENSITIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA CELL; SCIATIC NERVE; SENSITIZATION; SHAM PROCEDURE; SPINAL CORD DORSAL HORN; SPINAL GANGLION; STIMULUS RESPONSE; THERMAL STIMULATION; THERMAL STIMULUS TEST; TIBIA; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE TUMOR; COMPLICATION; DRUG EFFECTS; GENETICS; METABOLISM; PAIN MEASUREMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; SPINAL CORD; TUMOR CELL LINE;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; GANGLIA, SPINAL; HYPERALGESIA; MALE; MICE; MICE, KNOCKOUT; OLIGOPEPTIDES; PAIN MEASUREMENT; PAIN THRESHOLD; RECEPTOR, PAR-2; SCIATIC NERVE; SPINAL CORD; UP-REGULATION;

EID: 84898911895     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2013.00372.x     Document Type: Article

References (44)

1. Ahmed, A.S., Li, J., Erlandsson-Harris, H., Stark, A., Bakalkin, G., Ahmed, M., (2012). Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis. Pain 153, 18-26.
2. Alier, K.A., Endicott, J.A., Stemkowski, P.L., Cenac, N., Cellars, L., Chapman, K., Andrade-Gordon, P., Vergnolle, N., Smith, P.A., (2008). Intrathecal administration of proteinase-activated receptor-2 agonists produces hyperalgesia by exciting the cell bodies of primary sensory neurons. J Pharmacol Exp Ther 324, 224-233.
3. Amadesi, S., Nie, J., Vergnolle, N., Cottrell, G.S., Grady, E.F., Trevisani, M., Manni, C., Geppetti, P., McRoberts, J.A., Ennes, H., Davis, J.B., Mayer, E.A., Bunnett, N.W., (2004). Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 24, 4300-4312.
4. Cain, D.M., Wacnik, P.W., Turner, M., Wendelschafer-Crabb, G., Kennedy, W.R., Wilcox, G.L., Simone, D.A., (2001). Functional interactions between tumor and peripheral nerve: Changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J Neurosci 21, 9367-9376.
5. Chen, Y., Yang, C., Wang, Z.J., (2011). Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience 193, 440-451.
6. Chien, L.Y., Cheng, J.K., Chu, D., Cheng, C.F., Tsaur, M.L., (2007). Reduced expression of A-type potassium channels in primary sensory neurons induces mechanical hypersensitivity. J Neurosci 27, 9855-9865.
7. Coleman, R.E., (2006). Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12, 6243s-6249s.
8. Dai, Y., Moriyama, T., Higashi, T., Togashi, K., Kobayashi, K., Yamanaka, H., Tominaga, M., Noguchi, K., (2004). Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 24, 4293-4299.
9. Dai, Y., Wang, S., Tominaga, M., Yamamoto, S., Fukuoka, T., Higashi, T., Kobayashi, K., Obata, K., Yamanaka, H., Noguchi, K., (2007). Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J Clin Invest 117, 1979-1987.
10. Dery, O., Corvera, C.U., Steinhoff, M., Bunnett, N.W., (1998). Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases. Am J Physiol 274, C1429-C1452.
11. Fan, G.H., Wang, L.Z., Qiu, H.C., Ma, L., Pei, G., (1999). Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol Pharmacol 56, 39-45.
12. Gan, J., Greenwood, S.M., Cobb, S.R., Bushell, T.J., (2011). Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase-activated receptor-2. Br J Pharmacol 163, 984-994.
13. Ghilardi, J.R., Rohrich, H., Lindsay, T.H., Sevcik, M.A., Schwei, M.J., Kubota, K., Halvorson, K.G., Poblete, J., Chaplan, S.R., Dubin, A.E., Carruthers, N.I., Swanson, D., Kuskowski, M., Flores, C.M., Julius, D., Mantyh, P.W., (2005). Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci 25, 3126-3131.
14. Hoogerwerf, W.A., Zou, L., Shenoy, M., Sun, D., Micci, M.A., Lee-Hellmich, H., Xiao, S.Y., Winston, J.H., Pasricha, P.J., (2001). The proteinase-activated receptor 2 is involved in nociception. J Neurosci 21, 9036-9042.
15. Huang, Z.J., Li, H.C., Cowan, A.A., Liu, S., Zhang, Y.K., Song, X.J., (2012). Chronic compression or acute dissociation of dorsal root ganglion induces cAMP-dependent neuronal hyperexcitability through activation of PAR2. Pain 153, 1426-1437.
16. Ikeda, H., Stark, J., Fischer, H., Wagner, M., Drdla, R., Jager, T., Sandkuhler, J., (2006). Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science 312, 1659-1662.
17. Jimenez-Andrade, J.M., Ghilardi, J.R., Castaneda-Corral, G., Kuskowski, M.A., Mantyh, P.W., (2011). Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain. Pain 152, 2564-2574.
18. Kawabata, A., Kawao, N., Itoh, H., Shimada, C., Takebe, K., Kuroda, R., Masuko, T., Kataoka, K., Ogawa, S., (2002). Role of N-methyl-D-aspartate receptors and the nitric oxide pathway in nociception/hyperalgesia elicited by protease-activated receptor-2 activation in mice and rats. Neurosci Lett 329, 349-353.
19. Lam, D.K., Dang, D., Zhang, J., Dolan, J.C., Schmidt, B.L., (2012). Novel animal models of acute and chronic cancer pain: A pivotal role for PAR2. J Neurosci 32, 14178-14183.
20. Lam, D.K., Schmidt, B.L., (2010). Serine proteases and protease-activated receptor 2-dependent allodynia: A novel cancer pain pathway. Pain 149, 263-272.
21. Lee, S.E., Kim, J.H., (2007). Involvement of substance P and calcitonin gene-related peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat. Neurosci Res 58, 245-249.
22. Liu, S., Liu, W.T., Liu, Y.P., Dong, H.L., Henkemeyer, M., Xiong, L.Z., Song, X.J., (2011). Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents. Cancer Res 71, 4392-4402.
23. Liu, X.G., Sandkuhler, J., (1998). Activation of spinal N-methyl-D-aspartate or neurokinin receptors induces long-term potentiation of spinal C-fibre-evoked potentials. Neuroscience 86, 1209-1216.
24. Mantyh, P.W., (2006). Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci 7, 797-809.
25. McRoberts, J.A., Coutinho, S.V., Marvizon, J.C., Grady, E.F., Tognetto, M., Sengupta, J.N., Ennes, H.S., Chaban, V.V., Amadesi, S., Creminon, C., Lanthorn, T., Geppetti, P., Bunnett, N.W., Mayer, E.A., (2001). Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 120, 1737-1748.
26. Niiyama, Y., Kawamata, T., Yamamoto, J., Omote, K., Namiki, A., (2007). Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons. Neuroscience 148, 560-572.
27. Nishimura, S., Ishikura, H., Matsunami, M., Shinozaki, Y., Sekiguchi, F., Naruse, M., Kitamura, T., Akashi, R., Matsumura, K., Kawabata, A., (2010). The proteinase/proteinase-activated receptor-2/transient receptor potential vanilloid-1 cascade impacts pancreatic pain in mice. Life Sci 87, 643-650.
28. Noda, Y., Nabeshima, T., (2004). Opiate physical dependence and N-methyl-D-aspartate receptors. Eur J Pharmacol 500, 121-128.
29. Noorbakhsh, F., Vergnolle, N., Hollenberg, M.D., Power, C., (2003). Proteinase-activated receptors in the nervous system. Nat Rev Neurosci 4, 981-990.
30. Nyberg, P., Ylipalosaari, M., Sorsa, T., Salo, T., (2006). Trypsins and their role in carcinoma growth. Exp Cell Res 312, 1219-1228.
31. Pan, H.L., Zhang, Y.Q., Zhao, Z.Q., (2010). Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCepsilon pathway in dorsal root ganglion neurons. Mol Pain 6, 85.
32. Peters, C.M., Ghilardi, J.R., Keyser, C.P., Kubota, K., Lindsay, T.H., Luger, N.M., Mach, D.B., Schwei, M.J., Sevcik, M.A., Mantyh, P.W., (2005). Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp Neurol 193, 85-100.
33. Ritchie, E., Saka, M., Mackenzie, C., Drummond, R., Wheeler-Jones, C., Kanke, T., Plevin, R., (2007). Cytokine upregulation of proteinase-activated- receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells. Br J Pharmacol 150, 1044-1054.
34. Schmidt, B.L., Hamamoto, D.T., Simone, D.A., Wilcox, G.L., (2010). Mechanism of cancer pain. Mol Interv 10, 164-178.
35. Schwei, M.J., Honore, P., Rogers, S.D., Salak-Johnson, J.L., Finke, M.P., Ramnaraine, M.L., Clohisy, D.R., Mantyh, P.W., (1999). Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 19, 10886-10897.
36. Seybold, V.S., (2009). The role of peptides in central sensitization. Handb Exp Pharmacol 194, 451-491.
37. Shih, M.H., Kao, S.C., Wang, W., Yaster, M., Tao, Y.X., (2012). Spinal cord NMDA receptor-mediated activation of mammalian target of rapamycin is required for the development and maintenance of bone cancer-induced pain hypersensitivities in rats. J Pain 13, 338-349.
38. Song, X.J., Hu, S.J., Greenquist, K.W., Zhang, J.M., LaMotte, R.H., (1999). Mechanical and thermal hyperalgesia and ectopic neuronal discharge after chronic compression of dorsal root ganglia. J Neurophysiol 82, 3347-3358.
39. Song, X.J., Wang, Z.B., Gan, Q., Walters, E.T., (2006). cAMP and cGMP contribute to sensory neuron hyperexcitability and hyperalgesia in rats with dorsal root ganglia compression. J Neurophysiol 95, 479-492.
40. Song, X.J., Zheng, J.H., Cao, J.L., Liu, W.T., Song, X.S., Huang, Z.J., (2008). EphrinB-EphB receptor signaling contributes to neuropathic pain by regulating neural excitability and spinal synaptic plasticity in rats. Pain 139, 168-180.
41. Steinhoff, M., Vergnolle, N., Young, S.H., Tognetto, M., Amadesi, S., Ennes, H.S., Trevisani, M., Hollenberg, M.D., Wallace, J.L., Caughey, G.H., Mitchell, S.E., Williams, L.M., Geppetti, P., Mayer, E.A., Bunnett, N.W., (2000). Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6, 151-158.
42. Suckow, S.K., Caudle, R.M., (2009). NMDA receptor subunit expression and PAR2 receptor activation in colospinal afferent neurons (CANs) during inflammation induced visceral hypersensitivity. Mol Pain 5, 54.
43. van den Beuken-Van Everdingen, M.H., de Rijke, J.M., Kessels, A.G., Schouten, H.C., van Kleef, M., Patijn, J., (2007). Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 18, 1437-1449.
44. Vergnolle, N., Bunnett, N.W., Sharkey, K.A., Brussee, V., Compton, S.J., Grady, E.F., Cirino, G., Gerard, N., Basbaum, A.I., Andrade-Gordon, P., Hollenberg, M.D., Wallace, J.L., (2001). Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 7, 821-826.